Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless”.
GlobalData on MSN
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.
Coming up: earnings from AMD, Palantir, top pharmaceutical and tech firms; private-sector employment report; consumer ...
The discussion turned to vital role of the human element despite AI’s increasing integration into recruitment. Recruiting leaders use AI to reduce administrative tasks, thereby giving them free time ...
Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Thank you for standing by. Welcome to the Kiniksa Pharmaceuticals ...
The Critical Medicines Act (CMA) addresses supply chain vulnerabilities by redefining procurement criteria, emphasizing quality, security, and environmental standards. European manufacturers gain ...
Demonstrated feasibility of effective DNA delivery with Company's xPhore nanoparticle technologyDNA delivery technology to be offered as GenePhore to biotech / pharma companiesAddressing large and gro ...
Anthill , a leading content excellence and technology partner to the life sciences industry, has announced the launch of Anthill Cloud™ — an ...
Vietnam Investment Review on MSN
Fosun Pharma Announces 2025Q3 Financial Results
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...
Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer ...
The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.
Key updates on Reliance, HDFC Bank, TCS, and more, highlighting strategic partnerships, order wins, and company developments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results